Home » Verus Pharmaceuticals Announces $98 Million Financing
Verus Pharmaceuticals Announces $98 Million Financing
Verus Pharmaceuticals, a pediatric-oriented company dedicated to identifying, developing and delivering solutions to address the unmet medical needs of children and those who care for them, announced the completion of a $98 million initial financing, including a $78 million Series A preferred stock financing. The $78 million Series A financing, believed to be the largest sum ever raised in a Series A round in San Diego, was led by Domain Associates and Prospect Venture Partners and included Paul Royalty Fund, MPM Capital, Montreux Equity Partners, Athenian Venture Partners, Windamere Venture Partners, and private investors.
()a href="http://www.medadnews.com/News/Index.cfm?articleid=246967" target="_blank">PharmaLive
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May